Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

AstraZeneca plc Vs British American Tobacco plc: Which Is The Better Dividend Stock?

| Peter Stephens

If you're looking for a great income, should you buy AstraZeneca plc (LON: AZN) or British American Tobacco plc (LON:…

Read more »

Investing Articles

Why The Tipsters Like AstraZeneca plc Better Than GlaxoSmithKline plc

| Alan Oscroft

AstraZeneca plc (LON: AZN) looks in better recovery shape than GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

Should You Follow Neil Woodford And Buy GlaxoSmithKline plc, AstraZeneca plc, Circassia Pharmaceuticals PLC, Oxford Pharmascience Group Plc And ReNeuron Group Plc?

| G A Chester

Could GlaxoSmithKline plc (LON:GSK), AstraZeneca plc (LON:AZN), Circassia Pharmaceuticals PLC (LON:CIR), Oxford Pharmascience Group Plc (LON:OXP) and ReNeuron Group Plc…

Read more »

Investing Articles

These Figures Suggest That AstraZeneca plc Is Undervalued

| Rupert Hargreaves

AstraZeneca plc (LON: AZN) looks expensive at first glance but the company is actually undervalued.

Read more »

Investing Articles

Should You Buy AstraZeneca plc Instead Of Hikma Pharmaceuticals Plc, BTG plc And GW Pharmaceuticals plc?

| Peter Stephens

Is there better opportunity to make a profit with AstraZeneca plc (LON: AZN) or sector peers Hikma Pharmaceuticals Plc (LON:…

Read more »

Investing Articles

How Safe Are GlaxoSmithKline plc And AstraZeneca plc’s Dividends?

| Alan Oscroft

The cash picture is starting to look better at GlaxoSmithKline plc (LON: GSK) And AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

3 Reasons Why GlaxoSmithKline plc And AstraZeneca plc Are Worth Buying Right Now

| Peter Stephens

These 2 pharmaceutical stocks could deliver stunning share price gains: GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)

Read more »

Investing Articles

3 Reasons I Believe GlaxoSmithKline plc Is One Step Ahead Of AstraZeneca plc

| Roland Head

Roland Head explains why he believe GlaxoSmithKline plc (LON:GSK) may currently be a better buy than AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Is Indivior PLC The Perfect Partner For AstraZeneca plc In Your Portfolio?

| Peter Stephens

Could now be the right time to add both Indivior PLC (LON: INDV) and AstraZeneca plc (LON: AZN) to your…

Read more »

Investing Articles

Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or AstraZeneca plc?

| Rupert Hargreaves

GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN) are two different companies for different investors.

Read more »

Investing Articles

Is Now A Good Time To Buy AstraZeneca plc?

| Kevin Godbold

AstraZeneca plc (LON: AZN) disappoints on earnings, but R&D and deal-making promise growth ahead

Read more »

Investing Articles

Is It Game Over For AstraZeneca plc Shareholders?

| Alessandro Pasetti

Pfizer Inc. (NYSE:PFE) is not going to make a comeback for AstraZeneca plc (LON:AZN), whose shareholders are in trouble now,…

Read more »